United Imaging, a leading global manufacturer of advanced medical imaging and radiotherapy equipment, is launching its next-generation PET/CT systems, the uMI Panvivo and the uMI Panorama GS, and showcasing the uMI AI Solution at the European Association of Nuclear Medicine (EANM) 2024 Congress taking place from 19-23 October in Hamburg, Germany. By sponsoring the Young Authors’ Award and the Technologists’ Award at this year's meeting, United Imaging continues to demonstrate its commitment to fostering innovation and advancing the field of molecular imaging and nuclear medicine worldwide.
The uMI Panvivo is a new PET/CT platform that brings the latest technology and advances directly into clinical reality and future development. This PET/CT system has received FDA 510(k) clearance. With exceptional 219 ps TOF resolution, 2.9 mm NEMA spatial resolution and 181 cps/kBq effective sensitivity, the system delivers uncompromised clarity and lesion detectability, enhancing clinical confidence and capabilities. Its expandable architecture is ready to meet the ever-increasing demand for molecular imaging, allowing medical professionals to scale up capacity and unlock the full potential of clinical practice and research. Meanwhile, its compact, air-cooled design makes it truly accessible without the need for an equipment room. The patient-friendly design with extra-large bore diameter and ambient lighting provides a comfortable scanning experience.
Designed to set a new gold standard in molecular imaging and advance whole-body PET imaging, the uMI Panorama GS is the flagship of the uMI Panorama family. This PET/CT system has received FDA 510(k) clearance and is CE marked. With an impressive 148 cm axial field of view (AFOV), it enables comprehensive whole-body imaging in a single bed position. Designed to improve the patient experience and expand research capabilities, the system offers exceptional functional and anatomical imaging capabilities, redefining quantification accuracy for precise lesion detection. It is also the first long axial FOV PET/CT system to achieve a time resolution threshold of 180 ps.
AI Solution for Molecular Imaging (MI) enhances clinical workflows with advanced artificial intelligence, covering the entire workflow from image acquisition and analysis to reporting and biomedical research. It provides clinicians with powerful tools to improve diagnostic accuracy and efficiency. Powered by large language models, our solution delivers intelligent reporting and streamlined workflows to help clinicians make more informed, data-driven decisions. Within this solution, the CE-marked uAI MI Oncology application plays a key role in the image interpretation phase, helping physicians to analyse PET/CT images for more accurate and accessible cancer diagnosis.
Over the past year, United Imaging has driven significant progress in molecular imaging across Europe. The installation of the world’s first total-body PET/CT system, uEXPLORER, at two leading hospitals in Italy is a major step forward. The company also expanded its presence in Western Europe, installing MI systems in Germany and France. With new offices established in the UK and Spain, and numerous installations underway, United Imaging remains committed to delivering advanced medical technology to Europe’s diverse customer base.
United Imaging’s commitment to global expansion and innovation reflects its dedication to creating value for customers and improving healthcare outcomes worldwide. Through continued investment in research and development, the company is consolidating its leadership in the medical imaging field, advancing clinical research, and improving patient care, while enhancing local operations to drive growth and strengthen regional collaborations globally.
About United Imaging
At United Imaging, we develop and manufacture advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging diagnosis and treatment. Founded in 2011, our company has subsidiaries and R&D centres in China, the United States, Poland, Dubai and other parts of the world. With a cutting-edge digital portfolio and a mission of Equal Healthcare for All, we are helping to drive industry progress and bold change.
